Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and feasibility randomized controlled trial, presented as a late-breaking study at the 2018 American Heart Association meeting. Learn more at ProtectedPCI.com/DAIC.

Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and feasibility randomized controlled trial, presented as a late-breaking study at the 2018 American Heart Association meeting. Learn more at ProtectedPCI.com/DAIC.

Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic support with the Impella 2.5 heart pump during high-risk PCI can reduce the risk of AKI even when those patients had pre-existing kidney disease and a low ejection fraction. For more information: http://bit.ly/2Pfaqxh

Organizations who are embarking on an enterprise imaging journey share many of the same questions and concerns regarding how to best optimize workflow across providers, departments and facilities; which technologies will provide the best fit for achieving the future vision; and how to maximize value and accelerate return on investment by driving adoption and improving satisfaction among providers and healthcare consumers (patients).

We, Paragon Consulting Partners LLC (PCP Imaging), are a team of passionate healthcare professionals that bring over 100 years of collective clinical, technical and business leadership experience within the healthcare IT and imaging informatics industries. In this video we address the key challenges and considerations faced by organizations undertaking an Enterprise Imaging journey, and how a trusted partner can contribute valuable expertise and guidance that enable healthcare organizations and vendors of any size to successfully tackle even their most challenging enterprise imaging initiatives. For more information, visit pcpimaging.com.

Shimadzu Medical Systems highlighted new features of its Trinias Interventional X-ray line at the America College of Cardiology (ACC) 2017. A key feature of Trinias, is the ability to image from fingertip to fingertip during a transradial approach, which makes for much shorter hospital stay with the patient up and moving almost immediately after the procedure. Features Like RSM-DSA, a type of motion correction subtraction, eliminating the artifacts from the patient motion during acquisition while STENTVIEW, is an enhanced visualization during stent placement in real-time. Shimadzu also highlighted its partnership with Raysafe and its real-time staff radiation dose monitoring solution. For more information: http://shimadzu.com/med/products/angio/index.html

Tom Kloetzly, sales and marketing VP for Shimadzu Medical Systems USA, explains the evolution of Shimadzu Corporation since its founding 142 years ago. Kloetzly focuses on the Trinias Interventional X-ray line shown at RSNA 2016. Kloetzly states “A key feature of Trinias, is the ability to image from fingertip to fingertip during a transradial approach which makes for much shorter hospital stay with the patient up and moving almost immediately after the procedure. Features Like RSM-DSA, a type of motion correction subtraction, eliminates patient movement during acquisition while STENTVIEW, is an enhanced visualization during stent placement in real-time." For more information: www.shimadzu.com/med/products/angio/index.html.

The shift to value-based payment models requires focused attention on quality and cost. Lumedx’s Cardiovascular Performance Program offers a new approach to managing this transition so hospitals can improve outcomes — and dramatically reduce costs. See how complications reduction, cost-per-case variations and other key metrics delivered in real-time can drive radical change. For more information, visit www.lumedx.com.

Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and feasibility randomized controlled trial, presented as a late-breaking study at the 2018 American Heart Association meeting. Learn more at ProtectedPCI.com/DAIC.

Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and feasibility randomized controlled trial, presented as a late-breaking study at the 2018 American Heart Association meeting. Learn more at ProtectedPCI.com/DAIC.

In 2009, the GuideLiner Catheter revolutionized the concept of guide extension, creating new possibilities in interventional cardiology. Now in its third generation, the GuideLiner V3 Catheter continues to build on a history of innovation and performance — one that has been demonstrated with more than half a million catheters in cath labs around the world.

Teleflex also offers a family of Turnpike Catheters. These contain a robust multi-layer shaft that provides impressive flexibility, torque and tracking over a 0.014” guidewire in complex coronary and peripheral interventions. The unique five-layer composite shaft provides an ideal combination of flexibility and torque response to help navigate through complex anatomy while the outer polymer layer paired with a 60 cm distal hydrophilic coating facilitates smooth catheter delivery. This portfolio consists of the Turnpike Catheter (standard version), the Turnpike Spiral Catheter, the Turnpike Gold Catheter, and the Turnpike LP Catheter. Each catheter configuration contains a specific design element to address various clinical challenges in complex procedures

This year, Teleflex acquired two well-known PTCA balloon catheters. The Chocolate XD PTCA Balloon Catheter is a specialty angioplasty balloon, used in the pre-dilatation and treatment of coronary lesions. The balloon’s proprietary nitinol constraining structure creates “pillows” and “grooves” that are designed to provide controlled dilatation while minimizing vessel wall trauma.

The Glider PTCA Balloon Catheter is a semi-compliant balloon with a skived tip and low entry profile. The tip design, coupled with hydrophilic coating and an innovative, torqueable shaft, allows for precise tip orientation for use in crossing complex lesions and stent struts.

Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic support with the Impella 2.5 heart pump during high-risk PCI can reduce the risk of AKI even when those patients had pre-existing kidney disease and a low ejection fraction. For more information: http://bit.ly/2Pfaqxh

Ashish Pershad, M.D., medical director, structural heart program, Banner University Medical Heart Institute, Phoenix, explains the difference he found between the FDA cleared Watchman left atrial appendage (LAA) occluder and the Abbott Amplatzer Amulet device now in U.S. trials. He spoke on these differences at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference.

Example of GE Healthcare’s FetalHQ software for the ultrasound imaging of fetal hearts. The new tool runs on GE Healthcare’s Voluson ultrasound systems and is the first tool to simultaneously examine the size, shape and function of the fetal heart echocardiography for congenital heart evaluations.

A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS. They explain the use of shields, technique and use of newer angiography technologies to reduce X-ray radiation dose in the cardiac cath labs at Henry Ford Hospital, Detroit.

Leslee Shaw, Ph.D., professor of cardiology and radiology, Weill Cornell Medical Center, New York, and past-president of the Society of Cardiovascular Computed Tomography (SCCT), explains how cardiac imaging will be used in the ISCHEMIA Trial to assess treatment strategies for patients with stable ischemic heart disease. The trial was discussed by Shaw at the 2018 American Society of Nuclear Cardiology (ASNC) meeting.

Leslee Shaw, Ph.D., professor of cardiology and radiology, Weill Cornell Medical Center, New York, and past-president of the Society of Cardiovascular Computed Tomography (SCCT), explains how cardiac imaging will be used in the ISCHEMIA Trial to assess treatment strategies for patients with stable ischemic heart disease. The trial was discussed by Shaw at the 2018 American Society of Nuclear Cardiology (ASNC) meeting.

Kim A. Williams, Sr., M.D., MACC, MASNC, FAHA, FESC, cardiology division chief and James B. Herrick professor at Rush University Medical Center, discusses the importance of nuclear cardiology in preventive medicine, and previews his upcoming keynote lecture at the 2018 annual meeting of the American Society of Nuclear Cardiology (ASNC), Sept. 6-9 in San Francisco.

Watch the related VIDEO ASNC 2018 Program Preview, where Rami Doukky, M.D., professor of medicine, preventive medicine and radiology, and chief of the Division of Cardiology at Cook County Health and Hospitals System, discusses new additions to the ASNC meeting program for 2018.

Partho Sengupta, M.D., DM, FACC, FASE, chief division of cardiology, director of cardiac imaging, West Virginia University Heart and Vascular Institute, explains how artificial intelligence is being integrated into echocardiography and used to mine big data to better assess patients at the American Society of Echocardiography (ASE) 2018 meeting.

Ashish Pershad, M.D., medical director, structural heart program, Banner University Medical Heart Institute, Phoenix, explains the difference he found between the FDA cleared Watchman left atrial appendage (LAA) occluder and the Abbott Amplatzer Amulet device now in U.S. trials. He spoke on these differences at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference.

Malissa Wood, M.D., co-director of the Corrigan Women’s Heart Health Program, Massachusetts General Hospital, explains the the recent debate and data for screening all student athletes for SCA during the American Society of Echocardiography (ASE) 2018 meeting.

A new clinical trial at The Ohio State University Wexner Medical Center is examining an implanted device that uses vagus nerve stimulation to help stroke patients regain motor function. The Vivistim device is similar to a pacemaker, which uses leads to electrically stimulate the brain.

The Zoll LifeVest is a temporary, wearable defibrillator designed as a safety net for patients, especially those being evaluated for a permanent implantable cardioverter defibrillator (ICD). The Vest Prevention of Early Sudden Death Trial (VEST), presented at ACC 2018, was the first randomized, controlled, multi-center trial of the wearable cardioverter defibrillator. It looked to see if this device could effectively reduce sudden death in patients who had recently suffered a heart attack and had reduced heart function. Read more about the VEST Trial.

Take a video tour of some of the medical devices designed to improve patient care, improve patient engagement and increase physiologic monitoring highlighted at the 2018 Consumer Electronics Show (CES). One of the most interesting technologies is a flexible electronics ECG monitor that can bend and twist with the skin and interfaces with a smartphone app. The exhibition includes more than 3,000 vendors and more than 170,000 attendees. For more examples of future healthcare technologies, watch the VIDEO “Editor's Choice of Future Healthcare Technologies at HIMSS.”

Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pittsburgh Medical Center, explains the new mobile application he developed, which lets users visually model the forces at work during an MRI exam on patients with implanted medical devices, at the 2017 Radiological Society of North America (RSNA) meeting.

Example of GE Healthcare’s FetalHQ software for the ultrasound imaging of fetal hearts. The new tool runs on GE Healthcare’s Voluson ultrasound systems and is the first tool to simultaneously examine the size, shape and function of the fetal heart echocardiography for congenital heart evaluations.

A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS. They explain the use of shields, technique and use of newer angiography technologies to reduce X-ray radiation dose in the cardiac cath labs at Henry Ford Hospital, Detroit.

Suhny Abbara, M.D., FSCCT, chief of cardiothoracic imaging and chair of the CT operations committee, University of Texas Southwestern Medical Center, Dallas, incoming president of the Society of Cardiovascular Computed Tomography (SCCT), and editor of the new RSNA journal Radiology: Cardiothoracic Imaging. He spoke to DAIC at SCCT 2018 meeting.